<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(4)</volume><submitter>Sun Y</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>We aimed to investigate the diagnostic value of dynamic 2-deoxy-2-[&lt;sup>18&lt;/sup>F]-fluoro-D-glucose positron emission tomography-computed tomography in non-small cell lung cancer and fluoro-D-glucose hypermetabolic lymph nodes.&lt;h4>Methods&lt;/h4>Patients who made an active appointment for positron emission tomography-computed tomography were randomly enrolled by referring to previous imaging data and clinical information. Finally, 34 histopathologically confirmed non-small cell lung cancers (18 adenocarcinoma and 16 squamous cell carcinoma cases) were prospectively studied using dynamic and static 2-deoxy-2-[&lt;sup>18&lt;/sup>F]-fluoro-D-glucose positron emission tomography-computed tomography imaging (the diagnostic study has not yet been registered on a clinical trial platform</pubmed_abstract><journal>Quantitative imaging in medicine and surgery</journal><pagination>2556-2567</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10102752</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Diagnostic value of dynamic &lt;sup>18&lt;/sup>F-FDG PET/CT imaging in non-small cell lung cancer and FDG hypermetabolic lymph nodes.</pubmed_title><pmcid>PMC10102752</pmcid><pubmed_authors>Cao L</pubmed_authors><pubmed_authors>Xiao L</pubmed_authors><pubmed_authors>Wang B</pubmed_authors><pubmed_authors>Yu S</pubmed_authors><pubmed_authors>Zhai W</pubmed_authors><pubmed_authors>Liu C</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Sun Y</pubmed_authors><pubmed_authors>Xin J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Diagnostic value of dynamic &lt;sup>18&lt;/sup>F-FDG PET/CT imaging in non-small cell lung cancer and FDG hypermetabolic lymph nodes.</name><description>&lt;h4>Background&lt;/h4>We aimed to investigate the diagnostic value of dynamic 2-deoxy-2-[&lt;sup>18&lt;/sup>F]-fluoro-D-glucose positron emission tomography-computed tomography in non-small cell lung cancer and fluoro-D-glucose hypermetabolic lymph nodes.&lt;h4>Methods&lt;/h4>Patients who made an active appointment for positron emission tomography-computed tomography were randomly enrolled by referring to previous imaging data and clinical information. Finally, 34 histopathologically confirmed non-small cell lung cancers (18 adenocarcinoma and 16 squamous cell carcinoma cases) were prospectively studied using dynamic and static 2-deoxy-2-[&lt;sup>18&lt;/sup>F]-fluoro-D-glucose positron emission tomography-computed tomography imaging (the diagnostic study has not yet been registered on a clinical trial platform</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Apr</publication><modification>2025-04-04T12:44:37.623Z</modification><creation>2025-04-04T12:44:37.623Z</creation></dates><accession>S-EPMC10102752</accession><cross_references><pubmed>37064404</pubmed><doi>10.21037/qims-22-725</doi></cross_references></HashMap>